Comparing Semaglutide and Tirzepatide While both semaglutide and tirzepatide are effective in managing obesity and type 2 diabetes, their mechanisms of action differ slightly: Semaglutide is a GLP-1 receptor agonist that primarily works by: - Slowing gastric emptying - Reducing appetite through brain signaling - Stimulating insulin release from the pancreas - Decreasing glucagon secretion Tirzepatide, on the other hand, is a dual GIP and GLP-1 receptor agonist, often referred to as a "twincretin"[8]
What affects whether you notice anything at all: Whether you had a true nutrient deficiency to correct (especially for B12-related fatigue) Your calorie intake, protein, and consistency Sleep, stress, and movement Whether youre also using evidence-based tools (like FDA-indicated GLP-1 options when appropriate) Medical disclaimer This article is for education only and is not medical advice
However, anecdotal post-marketing reports suggest that some individuals do experience cognitive symptoms whilst taking GLP-1 receptor agonists, though the incidence remains unknown
GHK-Cu and Gene Expression Research Research using the Broad Institutes Connectivity Map found that GHK is capable of up- and downregulating at least 4,000 human genes, with studies identifying 47 DNA repair genes stimulated and 5 suppressed findings that suggest a broad regulatory role at the genomic level